| __timestamp | BioCryst Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 31354781 |
| Thursday, January 1, 2015 | 72758000 | 43445817 |
| Friday, January 1, 2016 | 61008000 | 66489820 |
| Sunday, January 1, 2017 | 66962000 | 96886134 |
| Monday, January 1, 2018 | 84888000 | 153793000 |
| Tuesday, January 1, 2019 | 107068000 | 148369000 |
| Wednesday, January 1, 2020 | 122964000 | 151934000 |
| Friday, January 1, 2021 | 208808000 | 198532000 |
| Saturday, January 1, 2022 | 253297000 | 112128000 |
| Sunday, January 1, 2023 | 216566000 | 76192000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, TG Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated significant commitment to innovation. From 2014 to 2023, BioCryst Pharmaceuticals increased its R&D spending by over 300%, peaking in 2022 with a 253 million dollar investment. Meanwhile, TG Therapeutics saw a remarkable 500% growth in R&D expenses, reaching its zenith in 2021 with nearly 199 million dollars.
This trend underscores the fierce competition and rapid advancements in the biotech sector. While BioCryst's R&D spending surged in the latter half of the decade, TG Therapeutics maintained a steady upward trajectory, highlighting its strategic focus on long-term innovation. As these companies continue to push the boundaries of medical science, their R&D investments remain a testament to their dedication to groundbreaking discoveries.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.